00:00It's Benzinga, bringing Wall Street to Main Street.
00:02OpenAI introduced GPT Rosalind, an artificial intelligence model designed to support research
00:08across biochemistry, drug discovery, and translational medicine as it expands into
00:13life sciences. According to Reuters, the company said demand for AI tools and research is rising
00:18across pharmaceutical companies, academic institutions, and biotech firms. OpenAI said
00:24the model supports evidence synthesis, hypothesis generation, and experimental planning.
00:30Researchers can query databases, read scientific papers, and suggest experiments.
00:36GPT Rosalind is available as a research preview in ChatGPT, Codex, and the API for qualified users.
00:43OpenAI also launched a free life sciences plug-in for Codex with access to over 50 tools and data
00:48sources. The company is working with Amgen, Moderna, and Thermo Fisher Scientific.
00:52For all things money, visit Benzinga.com.
Comments